Introduction
Acute respiratory failure and pulmonary dysfunction is a significant cause of morbidity and mortality following cardiac surgery [1] [2] . This pulmonary dysfunction stems from impairment of gas exchange and lung mechanics secondary to multiple factors including use of cardiopulmonary bypass, activation of the inflammatory cascade, atelectasis, decreased thoracic compliance, pleural effusions, postoperative pain, and diaphragmatic dysfunction. Non-invasive positive pressure ventilation (NPPV) is often used to correct postoperative pulmonary dysfunction and to treat respiratory failure in the intensive care unit (ICU). Several studies do support the use of NPPV to treat postoperative respiratory failure after non-cardiac surgery [3] [4] [5] [6] .
Bilevel positive airway pressure (BiPAP) is a commonly used form of NPPV that uses higher pressures during inspiration compared to expiration. Many studies have looked at different methods of NPPV, including BiPAP to prevent and treat respiratory failure following cardiac surgery [7] [8] [9] . These studies have shown that BiPAP can improve hypoxemia and decrease atelectasis after extubation following cardiac surgery [7] [8] [9] [10] . However, there is not much evidence on the use of BiPAP in preventing re-intubation following cardiac surgery [8, 11] .
This observational study aimed to evaluate if the initiation of an extubation protocol for all post-operative cardiac patients in the cardiothoracic intensive care unit (CTICU) using intermittent BiPAP could reduce the rate of re-intubation. We hypothesized that our rates of re-intubation would decrease following the implementation of our BiPAP protocol. Secondarily, we sought to identify factors demonstrating increased risk for re-intubation following cardiac surgery.
Materials And Methods
A post-extubation BiPAP therapy protocol was designed by a multidisciplinary team of cardiac surgeons, respiratory therapists, and medical intensivists at our institution and was subsequently implemented in May 2014. Our protocol, which was applied to all post-cardiac surgery patients, consisted of one hour of BiPAP therapy, followed by three hours of a nasal cannula for 24 hours starting half an hour after extubation in all patients post-cardiac surgery.
Patients also used incentive spirometry and positive end-expiratory pressure (PEEP) therapy every two hours. If BiPAP could not be tolerated, the patient was placed on high flow nasal oxygen.
After obtaining approval of our institutional review board and waiving patient consent, 
Discussion
Pulmonary dysfunction is a common cause of morbidity following cardiac surgery [1] [2] 12] . Given the known detrimental effects this has on postoperative outcomes [1] [2] 12] , it is imperative that respiratory failure is treated early to prevent reintubation. NPPV is used successfully to treat the respiratory failure of various etiologies, as well as, postoperative respiratory failure following non-cardiac surgery [3] [4] [5] [6] . There is also some data to suggest that NPPV can be used to treat respiratory failure following cardiac surgery [8] [9] 13] . BiPAP is safe, and improves hypoxemia and decreases atelectasis following cardiac surgery [7] [8] [9] [10] . However, there is limited data to suggest that BiPAP can be used to decrease reintubation rates following cardiac surgery [8, 11] .
In 2014, a combination of cardiac surgeons, respiratory therapists, and medical intensivists at our institution developed a BiPAP therapy protocol that was instituted once a patient was extubated following every cardiac surgery. This protocol placed patients on BiPAP for one hour and then a nasal cannula for three hours, starting half an hour after extubation. This cycle is repeated for 24 hours. This protocol was devised to reduce the reintubation rates for postcardiac surgery patients. Also, it was thought that by developing a specific protocol, our nursing and respiratory therapy staff would have a simplified and structured outline for postextubation respiratory management. Our protocol was developed after reviewing numerous studies, including a study from Celebi et al. that showed that following cardiac surgery, postextubation hypoxemia, and atelectasis were both improved with intermittent BiPAP therapy [8] .
The primary outcome of our study failed to show a difference in reintubation rates after the establishment of post-extubation intermittent BiPAP therapy protocol following cardiac surgery. This is consistent with Sagiroglu et al., who showed the early and prophylactic use of BiPAP without acute respiratory failure in the early post-extubation period following cardiac surgery did not improve reintubation rates [11] . We identified several possible key factors for the lack of significance: (a) the BiPAP population had more co-morbidities including cerebrovascular disease, prior heart failure, prior coronary intervention, former smokers, history of pneumonia, and use of daily bronchodilators; (b) It is also possible that the patients in the BiPAP arm were getting extubated too early. The STS uses time-to-extubation less than six hours following surgery as the benchmark for early extubation, which may contribute to pushing patients to be extubated within this time frame. Our study showed significantly more patients in the BiPAP group getting extubated within this 6-hour mark. However, Crawford et al. showed that operative mortality, major morbidity, and prolonged LOS did not increase until time-to-extubation reached at least 12 hours [14] . The pressure to extubate within six hours may lead to early extubation of some patients; (c) Lastly, are some factors more important than simply increasing oxygen levels and decreasing atelectasis in preventing reintubation? Our study showed that longer operating room and bypass times are associated with an increased risk of reintubation. So, it is possible that these factors and others are more important than increasing oxygen levels and decreasing atelectasis with BiPAP for preventing reintubation.
As for our secondary outcomes, which looked at identifying risk factors for re-intubation postcardiac surgery, there were no significant differences between the cohorts when comparing post-operative pneumonia, 30-day readmissions, and 30-day mortality. The BiPAP group did have a significantly shorter total intubation time and total hospital LOS.
Several significant patient risk factors for re-intubation were identified as part of our study. These included prior valve surgery, congestive heart failure, and chronic lung disease. Our study also showed that emergent case status, longer operating room time, longer cardiopulmonary bypass times, and higher STS risk of mortality scores were associated with an increased risk of re-intubation. These risk factors are consistent with prior studies [15] [16] . Going forward, these risk factors should be kept in mind when deciding to extubate the patient. These specific patients are the population that may benefit from intermittent BiPAP therapy following extubation. However, further research is needed.
Our study has several limitations. First, our study did not consider how many patients did not complete the 24-hour protocol because they could not tolerate BiPAP. Many patients in our study found BiPAP uncomfortable and could not tolerate it. Past studies have looked at using high-flow nasal oxygen instead of BiPAP to improve oxygenation after extubation following cardiac and non-cardiac surgery [7, 17] . These studies showed that among cardiac and noncardiac surgery patients with or at-risk for respiratory failure, the use of high-flow nasal oxygen therapy compared with intermittent BiPAP did not result in a higher treatment failure rate. The patients kept on BiPAP because of worsening respiratory status were excluded. The specific reason for reintubation was not documented, and therefore could not be evaluated. Lastly, this is an observational study and used historical data for our control group.
Going forward, several factors should be considered. One, the reason for re-intubation should be documented and form a part of the protocol. There are many reasons for re-intubation including failure to clear secretions, weakness, altered mental status, smoking, etc. Acute respiratory failure can be further characterized by the cause such as due to hypoxia, hypercapnia, or a combination of both. Depending on the underlying cause and type of respiratory failure, BiPAP may not affect the underlying pathophysiologic process. Also, arterial blood gas data, as well as the STS risk of re-intubation score should be documented for each patient and could be used to further characterize patients at higher risk for re-intubation who could benefit from our protocol.
While an intermittent BiPAP protocol did not show a significant difference in re-intubation rates after cardiac surgery versus nasal cannula, subgroup analysis of re-intubated patients showed significant risk factors for re-intubation. These risk factors should be kept in mind by teams when considering post-operative extubation to avoid the associated detrimental outcomes.
Conclusions
While a BiPAP protocol did not show a significant difference in re-intubation rates after cardiac surgery, the subgroup analysis of re-intubated patients showed several significant risk factors for re-intubation. Early identification of these risk factors when considering extubation may help teams avoid associated morbidity and mortality outcomes.
